Symbols / NXL $0.37 +2.55% Nexalin Technology, Inc.

Healthcare • Medical Devices • United States • NCM
NXL Chart
About

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 7.60M
Enterprise Value 3.69M Income -8.22M Sales 301.65K
Book/sh 0.20 Cash/sh 0.18 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -0.95 PEG —
P/S 25.20 P/B 1.89 P/C —
EV/EBITDA -0.44 EV/Sales 12.23 Quick Ratio 4.29
Current Ratio 4.84 Debt/Eq — LT Debt/Eq —
EPS (ttm) -0.50 EPS next Y -0.39 EPS Growth —
Revenue Growth 5.33% Earnings 2026-03-25 11:00 ROA -118.41%
ROE -221.50% ROIC — Gross Margin 79.65%
Oper. Margin -14.04% Profit Margin 0.00% Shs Outstand 20.58M
Shs Float 17.86M Short Float 2.64% Short Ratio 1.41
Short Interest — 52W High 2.31 52W Low 0.34
Beta 4.23 Avg Volume 305.00K Volume 35.69K
Target Price $4.00 Recom None Prev Close $0.36
Price $0.37 Change 2.55%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$4.00
Mean price target
2. Current target
$0.37
Latest analyst target
3. DCF / Fair value
$-1.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.37
Low
$4.00
High
$4.00
Mean
$4.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-03-24 up Maxim Group Hold → Buy $5
2024-12-05 down Maxim Group Buy → Hold —
2024-10-09 init Maxim Group — → Buy $3
News
RSS: Latest NXL news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-29 OSSER LEONARD A Beneficial Owner of more than 10% of a Class of Security — 83,333 $0.00 $0
2025-09-29 HU BENJAMIN Director — 36,459 $0.00 $0
2025-09-29 OWENS DAVID Officer and Director — 36,459 $0.00 $0
2025-09-29 KAZDEN ALAN Director — 36,459 $0.00 $0
2025-03-12 SHELTON CAROLYN HAMBY Officer — 6,000 $2.20 $13,200
2025-02-04 OWENS DAVID Officer and Director — 1,000 $2.98 $2,980
2025-02-04 OWENS DAVID Officer and Director — 1,000 $3.10 $3,100
2025-01-28 OWENS DAVID Officer and Director — 1,500 $2.70 $4,050
2025-01-23 OWENS DAVID Officer and Director — 3,000 $2.50 $7,700
2024-12-20 OWENS DAVID Officer and Director — 1,000 $2.75 $2,750
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.30
+78.78%
0.17
+52.35%
0.11
-91.62%
1.32
Operating Revenue
0.27
+68.37%
0.16
+48.86%
0.11
-91.55%
1.29
Cost Of Revenue
0.06
+67.72%
0.04
+42.45%
0.03
-92.93%
0.36
Reconciled Cost Of Revenue
0.06
+67.72%
0.04
+42.45%
0.03
-92.93%
0.36
Gross Profit
0.24
+81.85%
0.13
+55.34%
0.09
-91.12%
0.96
Operating Expense
8.63
+9.44%
7.89
+36.42%
5.78
+107.13%
2.79
Research And Development
1.08
-9.02%
1.19
-38.03%
1.92
—
Selling General And Administration
7.55
+12.72%
6.70
+73.49%
3.86
+38.28%
2.79
General And Administrative Expense
7.55
+12.72%
6.70
+73.49%
3.86
+38.28%
2.79
Salaries And Wages
1.88
+25.28%
1.50
+8.08%
1.39
+99.96%
0.69
Other Gand A
5.67
+9.09%
5.20
+110.22%
2.47
+17.86%
2.10
Total Expenses
8.69
+9.71%
7.92
+36.44%
5.81
+84.09%
3.15
Operating Income
-8.39
-8.20%
-7.75
-36.13%
-5.70
-210.76%
-1.83
Total Operating Income As Reported
-8.39
-8.20%
-7.75
-36.13%
-5.70
-210.76%
-1.83
EBITDA
-8.37
-8.14%
-7.74
-35.97%
-5.69
-210.62%
-1.83
Normalized EBITDA
-8.50
-7.96%
-7.87
-20.35%
-6.54
-252.42%
-1.86
Reconciled Depreciation
0.02
+42.56%
0.02
+255.12%
0.00
+695.14%
0.00
EBIT
-8.39
-8.20%
-7.75
-36.13%
-5.70
-210.76%
-1.83
Total Unusual Items
0.13
-2.44%
0.13
-84.64%
0.85
+3595.58%
0.02
Total Unusual Items Excluding Goodwill
0.13
-2.44%
0.13
-84.64%
0.85
+3595.58%
0.02
Special Income Charges
—
0.00
-100.00%
0.61
+2583.71%
0.02
Other Special Charges
—
—
-0.61
-2583.71%
-0.02
Impairment Of Capital Assets
—
—
—
—
Net Income
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Pretax Income
-8.22
-8.00%
-7.61
-63.75%
-4.65
-173.81%
-1.70
Net Non Operating Interest Income Expense
0.01
+158.06%
0.00
+108.22%
-0.04
+34.60%
-0.06
Interest Expense Non Operating
—
—
—
0.06
Net Interest Income
0.01
+158.06%
0.00
+108.22%
-0.04
+34.60%
-0.06
Interest Expense
—
—
—
0.06
Interest Income Non Operating
0.01
—
—
—
Interest Income
0.01
—
—
—
Other Income Expense
0.16
+15.84%
0.14
-87.17%
1.09
+458.29%
0.19
Other Non Operating Income Expenses
0.03
+271.30%
0.01
-96.11%
0.24
+39.53%
0.17
Gain On Sale Of Security
0.13
-2.44%
0.13
-43.89%
0.23
—
Tax Provision
0.00
0.00
0.00
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Net Income From Continuing Operation Net Minority Interest
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Net Income From Continuing And Discontinued Operation
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Net Income Continuous Operations
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Normalized Income
-8.35
-7.91%
-7.74
-40.79%
-5.50
-219.38%
-1.72
Net Income Common Stockholders
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Diluted EPS
—
-0.83
-31.75%
-0.63
-110.00%
-0.30
Basic EPS
—
-0.83
-31.75%
-0.63
-110.00%
-0.30
Basic Average Shares
—
9.22
+25.26%
7.36
+32.03%
5.57
Diluted Average Shares
—
9.22
+25.26%
7.36
+32.03%
5.57
Diluted NI Availto Com Stockholders
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Earnings From Equity Interest Net Of Tax
-0.00
-121.60%
0.00
0.00
—
Total Other Finance Cost
—
-0.00
-108.22%
0.04
-34.60%
0.06
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
4.64
+9.77%
4.22
+16.27%
3.63
-51.13%
7.43
Current Assets
4.30
+8.54%
3.96
+15.49%
3.43
-53.81%
7.43
Cash Cash Equivalents And Short Term Investments
3.72
+6.99%
3.48
+18.03%
2.95
-57.84%
6.99
Cash And Cash Equivalents
0.65
+13.98%
0.57
-0.99%
0.58
+256.53%
0.16
Cash Financial
—
—
—
—
Other Short Term Investments
3.07
+5.61%
2.91
+22.69%
2.37
-65.33%
6.83
Receivables
0.08
+525.40%
0.01
+39.21%
0.01
+92.18%
0.00
Accounts Receivable
0.08
+525.40%
0.01
+39.21%
0.01
+92.18%
0.00
Inventory
0.13
-24.69%
0.17
+11.61%
0.16
+1.33%
0.15
Prepaid Assets
—
—
—
—
Other Current Assets
0.36
+23.64%
0.29
-6.99%
0.32
+15.93%
0.27
Total Non Current Assets
0.34
+28.46%
0.26
+29.49%
0.20
+2927.03%
0.01
Net PPE
—
0.00
-100.00%
0.00
-92.57%
0.01
Gross PPE
—
0.00
-100.00%
0.00
-94.40%
0.01
Accumulated Depreciation
—
—
-0.00
-23.06%
-0.00
Machinery Furniture Equipment
—
—
—
—
Other Properties
—
—
0.00
-94.40%
0.01
Goodwill And Other Intangible Assets
0.34
+28.89%
0.26
+147.07%
0.11
0.00
Other Intangible Assets
0.34
+28.89%
0.26
+147.07%
0.11
—
Investments And Advances
—
0.00
-99.10%
0.10
0.00
Long Term Equity Investment
—
0.00
-99.10%
0.10
0.00
Other Non Current Assets
—
0.00
—
—
Total Liabilities Net Minority Interest
0.89
+62.31%
0.55
+28.55%
0.43
-78.23%
1.95
Current Liabilities
0.89
+62.31%
0.55
+28.55%
0.43
-78.18%
1.95
Payables And Accrued Expenses
0.40
+30.21%
0.31
+13.25%
0.27
-77.40%
1.20
Payables
0.24
+56.83%
0.16
-2.25%
0.16
-75.77%
0.66
Accounts Payable
0.24
+56.83%
0.16
-2.25%
0.16
-75.77%
0.66
Current Accrued Expenses
0.15
+2.66%
0.15
+35.46%
0.11
-79.39%
0.54
Pensionand Other Post Retirement Benefit Plans Current
0.49
+103.33%
0.24
+60.00%
0.15
0.00
Current Debt And Capital Lease Obligation
—
—
0.00
-99.41%
0.75
Current Debt
—
—
—
0.70
Other Current Borrowings
—
—
—
0.20
Current Capital Lease Obligation
—
0.00
-100.00%
0.00
-91.21%
0.05
Current Deferred Liabilities
—
—
—
0.00
Current Deferred Revenue
—
—
—
0.00
Total Non Current Liabilities Net Minority Interest
0.00
0.00
0.00
-100.00%
0.00
Long Term Debt And Capital Lease Obligation
—
—
0.00
-100.00%
0.00
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
—
—
0.00
-100.00%
0.00
Stockholders Equity
3.75
+1.96%
3.68
+14.64%
3.21
-41.47%
5.48
Common Stock Equity
3.75
+1.96%
3.68
+14.64%
3.21
-41.47%
5.48
Capital Stock
0.02
+44.21%
0.01
+78.89%
0.01
+2.06%
0.01
Common Stock
0.02
+44.21%
0.01
+78.89%
0.01
+2.06%
0.01
Share Issued
19.19
+44.22%
13.30
+78.89%
7.44
+2.06%
7.29
Ordinary Shares Number
19.19
+44.22%
13.30
+78.89%
7.44
+2.06%
7.29
Additional Paid In Capital
96.60
+9.38%
88.31
+10.06%
80.24
+3.10%
77.82
Retained Earnings
-92.87
-9.71%
-84.65
-9.87%
-77.04
-6.42%
-72.39
Gains Losses Not Affecting Retained Earnings
0.00
+179.14%
-0.00
-26.67%
-0.00
-101.12%
0.04
Other Equity Adjustments
0.00
+179.14%
-0.00
-26.67%
-0.00
-101.12%
0.04
Total Equity Gross Minority Interest
3.75
+1.96%
3.68
+14.64%
3.21
-41.47%
5.48
Total Capitalization
3.75
+1.96%
3.68
+14.64%
3.21
-41.47%
5.48
Working Capital
3.41
-0.07%
3.41
+13.64%
3.00
-45.14%
5.48
Invested Capital
3.75
+1.96%
3.68
+14.64%
3.21
-48.10%
6.18
Total Debt
—
0.00
-100.00%
0.00
-99.41%
0.76
Net Debt
—
—
—
0.54
Capital Lease Obligations
—
0.00
-100.00%
0.00
-91.92%
0.06
Net Tangible Assets
3.41
-0.10%
3.42
+10.13%
3.10
-43.40%
5.48
Tangible Book Value
3.41
-0.10%
3.42
+10.13%
3.10
-43.40%
5.48
Available For Sale Securities
—
—
0.10
—
Current Notes Payable
—
—
0.00
-100.00%
0.50
Interest Payable
—
—
0.00
-100.00%
0.11
Investmentin Financial Assets
—
—
0.10
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.96
-25.69%
-3.94
-2.84%
-3.84
-73.10%
-2.22
Cash Flow From Continuing Operating Activities
-4.96
-25.69%
-3.94
-2.84%
-3.84
-73.10%
-2.22
Net Income From Continuing Operations
-8.22
-8.08%
-7.61
-63.64%
-4.65
-173.81%
-1.70
Depreciation Amortization Depletion
0.02
+42.56%
0.02
+255.12%
0.00
+695.14%
0.00
Depreciation
—
0.00
-100.00%
0.00
-5.98%
0.00
Amortization Cash Flow
0.02
+42.56%
0.02
+302.75%
0.00
0.00
Depreciation And Amortization
0.02
+42.56%
0.02
+255.12%
0.00
+695.14%
0.00
Amortization Of Intangibles
0.02
+42.56%
0.02
+302.75%
0.00
0.00
Other Non Cash Items
—
0.00
-91.26%
0.01
+103.48%
-0.16
Stock Based Compensation
3.12
-12.28%
3.56
+47.53%
2.41
+791.63%
0.27
Asset Impairment Charge
0.02
0.00
-100.00%
0.01
-81.45%
0.03
Operating Gains Losses
-0.13
-260.48%
-0.03
+95.87%
-0.85
-3595.58%
-0.02
Gain Loss On Investment Securities
-0.13
+2.44%
-0.13
+43.89%
-0.23
—
Change In Working Capital
0.23
+88.58%
0.12
+115.82%
-0.77
-21.26%
-0.63
Change In Receivables
-0.07
-1765.19%
-0.00
+18.25%
-0.00
-1876.28%
0.00
Changes In Account Receivables
-0.07
-1765.19%
-0.00
+18.25%
-0.00
-1876.28%
0.00
Change In Inventory
0.03
+247.18%
-0.02
-132.44%
-0.01
+94.53%
-0.14
Change In Prepaid Assets
-0.07
-414.49%
0.02
+150.87%
-0.04
+81.06%
-0.23
Change In Payables And Accrued Expense
0.34
+170.61%
0.13
+119.00%
-0.66
-667.34%
-0.09
Change In Accrued Expense
0.25
+94.66%
0.13
+179.16%
-0.16
-265.01%
0.10
Change In Payable
0.09
+2572.22%
-0.00
+99.28%
-0.50
-169.02%
-0.19
Change In Account Payable
0.09
+2572.22%
-0.00
+99.28%
-0.50
-169.02%
-0.19
Change In Other Working Capital
—
—
—
-0.13
Change In Other Current Liabilities
0.00
+100.00%
-0.00
+91.21%
-0.05
-10.35%
-0.05
Investing Cash Flow
-0.13
+77.15%
-0.58
-112.97%
4.45
+165.53%
-6.79
Cash Flow From Continuing Investing Activities
-0.13
+77.15%
-0.58
-112.97%
4.45
+165.53%
-6.79
Net PPE Purchase And Sale
—
—
—
—
Purchase Of PPE
—
—
—
—
Capital Expenditure
-0.10
+43.13%
-0.17
-55.85%
-0.11
—
Net Investment Purchase And Sale
-0.04
+91.37%
-0.41
-108.74%
4.66
+168.55%
-6.79
Purchase Of Investment
-40.76
-21.20%
-33.63
+8.16%
-36.62
-438.94%
-6.79
Sale Of Investment
40.73
+22.58%
33.22
-19.51%
41.28
0.00
Net Business Purchase And Sale
—
0.00
+100.00%
-0.10
0.00
Purchase Of Business
—
0.00
+100.00%
-0.10
0.00
Net Intangibles Purchase And Sale
-0.10
+43.13%
-0.17
-55.85%
-0.11
0.00
Purchase Of Intangibles
-0.10
+43.13%
-0.17
-55.85%
-0.11
0.00
Financing Cash Flow
5.17
+14.48%
4.52
+2358.09%
-0.20
-102.35%
8.51
Cash Flow From Continuing Financing Activities
5.17
+14.48%
4.52
+2358.09%
-0.20
-102.35%
8.51
Net Issuance Payments Of Debt
—
0.00
+100.00%
-0.20
-437.63%
-0.04
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
0.00
+100.00%
-0.20
-437.63%
-0.04
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
0.00
+100.00%
-0.20
-437.63%
-0.04
Net Short Term Debt Issuance
—
0.00
+100.00%
-0.20
-437.63%
-0.04
Net Common Stock Issuance
4.65
+2.88%
4.52
0.00
-100.00%
8.55
Proceeds From Stock Option Exercised
0.52
0.00
0.00
-100.00%
0.00
Changes In Cash
0.08
+1497.70%
-0.01
-101.38%
0.42
+183.66%
-0.50
Beginning Cash Position
0.57
-0.99%
0.58
+256.53%
0.16
-75.41%
0.66
End Cash Position
0.65
+13.98%
0.57
-0.99%
0.58
+256.53%
0.16
Free Cash Flow
-5.05
-22.84%
-4.11
-4.31%
-3.94
-78.03%
-2.22
Interest Paid Supplemental Data
—
—
—
—
Common Stock Issuance
4.65
+2.88%
4.52
0.00
-100.00%
8.55
Earnings Losses From Equity Investments
0.00
-99.09%
0.10
0.00
—
Issuance Of Capital Stock
4.65
+2.88%
4.52
0.00
-100.00%
8.55
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category